# Spironolactone for Hidradenitis Suppurativa

> **NCT04100083** · PHASE4 · WITHDRAWN · sponsor: **Medical University of South Carolina**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Spironolactone 50 MG
- **DRUG:** Spironolactone 100mg
- **DRUG:** Spironolactone 200 mg

## Key facts

- **NCT ID:** NCT04100083
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-21
- **Primary completion:** 2021-06-21
- **Final completion:** 2021-06-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100083, "Spironolactone for Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04100083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*